China SXT Pharmaceuticals schedules 2025 special shareholder meeting

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) announced Tuesday that it will hold a special meeting of shareholders in 2025. The company, based in Taizhou, Jiangsu, China, disclosed the meeting plans in a filing with the U.S. Securities and Exchange Commission.

According to the SEC filing, China SXT Pharmaceuticals will mail a notice of the 2025 special meeting of shareholders to its shareholders. The filing also includes a form of proxy card, which will be distributed to shareholders for voting purposes. Details regarding the date, time, location, and agenda of the special meeting were not provided in the filing.

The filing was signed by Co-Chief Executive Officers Feng Zhou and Simon Lim Sze Beng.

This information is based on a press release statement contained in the SEC filing.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.